Constitutive-activated KRAS mutation results from a point mutation most commonly seen in codons 12 and 13 in CRC, increasing the risk of cancer development and causing cancer cells, if formed, to proliferate uncontrollably and metastasize in the body [7]. Here, KRAS is linked to cancer.